Melatonin inhibits the migration of human lung adenocarcinoma A549 cell lines involving JNK/MAPK pathway

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Zhou, Qiaoyun ^a   Gui, Shuyu ^a   Zhou, Qing ^a   Wang, Yuan ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MELATONIN; MITOGEN ACTIVATED PROTEIN KINASE; MYOSIN LIGHT CHAIN; MYOSIN LIGHT CHAIN KINASE; OCCLUDIN; OSTEOPONTIN; STRESS ACTIVATED PROTEIN KINASE; ANTINEOPLASTIC AGENT; ANTIOXIDANT;

ARTICLE; CANCER CELL LINE; CANCER INHIBITION; CELL MIGRATION; CELL SURFACE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; LUNG ADENOCARCINOMA; MTT ASSAY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; UPREGULATION; WESTERN BLOTTING; WOUND HEALING; ADENOCARCINOMA; CELL MOTION; CELL SURVIVAL; DRUG EFFECTS; LUNG; LUNG NEOPLASMS; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; HUMANS; LUNG; LUNG NEOPLASMS; MAP KINASE SIGNALING SYSTEM; MELATONIN; OCCLUDIN;

EID: 84903759022     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101132     Document Type: Article

References (63)

1. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. A Cancer Journal for Clinicians 62: 10-29.
2. Petty RD, Nicolson MC, Kerr KM, Collie-Duguid E, Murray GI (2004) Gene expression profiling in non-small cell lung cancer: from molecular mechanisms to clinical application. Clinical Cancer Research 10: 3237-3248. (Pubitemid 38685427)
3. Dziadziuszko R, Hirsch FR (2008) Advances in genomic and proteomic studies of non-small-cell lung cancer: clinical and translational research perspective. Clinical Lung Cancer 9: 78-84. (Pubitemid 351631919)
4. Weight B, Peterse JL, Van't Veer LJ (2005) Breast cancer metastasis: markers and models. Nature Reviews Cancer 5: 591-602. (Pubitemid 41081385)
5. Vicente-Manzanares M, Zareno J, Whitmore L, Choi CK, Horwitz AF (2007) Regulation of protrusion, adhesion dynamics, and polarity by myosins IIA and IIB in migration cells. The Journal of Cell Biology 176: 573-580. (Pubitemid 46333973)
6. Tuck AB, Hota C, Wilson SM, Chambers AF (2003) Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways. Oncogene 22: 1198-1205. (Pubitemid 36363383)
7. Chew TL, Wolf WA, Gallagher PJ, Matsumura F, Chisholm RL (2002) A Fluorescent resonant energy transfer based biosensor reveals transient and regional myosin light chain kinasdxce activation in lamella and cleavage furrows. The Journal of Cell Biology 156: 543-553. (Pubitemid 34839901)
8. Kishi H, Mikawa T, Seto M, Sasaki Y, Kanayasu-Toyoda T, et al. (2000) Stable transfectants of smooth muscle cell line lacking the expression of myosin light chain kinase and their characterization with respect to the actomyosin system. The Journal of Biological Chemistry 275: 1414-1420. (Pubitemid 30051201)
9. Sodek J, Ganss B, McKee MD (2000) Osteopontin. Critical Reviews in Oral Biology&Medicine 11: 279-303.
10. Furuse M, Hirase T, Itoh M, Nagafuchi A, Yonemura S, et al. (1993) Occludin: a novel integral membrane protein localizing at tight junctions. The Journal of Cell Biology 123: 1777-1788. (Pubitemid 24012933)
11. Ando-Akatsuka Y, Saitou M, Hirase T, Kishi M, Sakakibara A, et al. (1996) Interspecies diversity of the occludin sequence: cDNA cloning of human, mouse, dog, and rat-kangaroo homologues. The Journal of Cell Biology 133: 43-47. (Pubitemid 126618596)
12. Fujimoto K (1995) Freeze-fracture replica electron microscopy combined with SDS digestion for cytochemical labeling of integral membrane proteins. Application to the immunogold labeling of intercellular junctional complexes. Journal of Cell Science 108: 3443-3449.
13. Dhawan P, Singh AB, Deane NG, No Y, Shiou SR, et al. (2005) Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer. Journal of Clinical Investigation 115: 1765-1776. (Pubitemid 40979715)
14. Hoover KB, Liao SY, Bryant PJ (1998) Loss of the tight junction MAGUK ZO-1 in breast cancer: relationship to glandular differentiation and loss of heterozygosity. The American Journal of Pathology 153: 1767-1773. (Pubitemid 28550664)
15. Tobioka H, Tokunaga Y, Isomura H, Kokai Y, Yamaguchi J, et al. (2004) Expression of occludin, a tight-junction associated protein, in human lung carcinomas. Virchows Arch 445: 472-476. (Pubitemid 39592750)
16. Gonzalez-Mariscal L, Tapia R, Chamorro D (2008) Crosstalk of tight junction components with signaling pathways. Biochimica et Biophysica Acta 1778: 729-756. (Pubitemid 351317800)
17. Chang L, Karin M (2001) Mammalian MAP kinase signaling cascades. Nature 410: 37-40. (Pubitemid 32225829)
18. Yang R, Piperdi S, Gorlick R (2008) Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcoma. Clinical Cancer Research 14: 6396-6404.
19. Ip YT, Davis RJ (1998) Signal transduction by the c-Jun N-terminal kinase (JNK)-from inflammation to development. Current Opinion in Cell Biology 10: 205-219. (Pubitemid 28174763)
20. Bogoyevitch MA, Kobe B (2006) Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases. Microbiology and Molecular Biology Reviews 70: 106121095.
21. Dominguez-Rodriguez A, Breu-Gonzalez P (2011) Melatonin: still a forgotten antioxidant. International Journal of Cardiology 149: 382.
22. Korkmaz A, Reiter RJ, Topal T, Manchester LC, Oter S, et al. (2009) Melatonin: an established antioxidant worthy of use in clinical trials. Molecular Medicine 15: 43-50.
23. Galano A, Tan DX, Reiter RJ (2011) Melatonin as a naturalally against oxidative stress: a physicochemical examination. Journal of Pineal Research 51: 1-16.
24. Bonnefont-Rousselot D, Collin F, Jore D, Gardès-Albert M (2011) Reaction mechanism of melatonin oxidation by reactive oxygen species in vitro. Journal of Pineal Research 50: 328-335.
25. Reiter RJ, Tan DX, Poeggeler B, Menendez-Pelaez, Chen L, et al. (1994) Melatonin as a free radical scavenger: implications for aging and age-related diseases. Annals of The New York Academy of Sciences 719: 1-12. (Pubitemid 24199963)
26. Tan DX, Chen LD, Poeggeler B, Manchester LC, Reiter RJ, et al. (1993) Melatonin: a potent endogenous hydroxyl radical scavenger. Endocrine Journal 1: 57-60.
27. Hill SM, Blask DE, Xiang S, Yuan L, Mao L, et al. (2011) Melatonin and associated signaling pathways that control normal breast epithelium and breast cancer. Journal of Mammary Gland Biology and Neoplasia 16: 235-245.
28. Messina G, Lissoni P, Marchiori P, Bartolacelli E, Brivio F, et al. (2010) Enhancement of the efficacy of cancer chemotherapy by the pineal hormone melatonin and its relation with the psychospiritual status of cancer patients. Journal of Research in Medical Sciences 15: 225-228.
29. Padillo FJ, Ruiz-Rabelo JF, Cruz A, Perea MD, Tasset I, et al. (2010) Melatonin and celecoxib improve the outcomes in hamsters with experimental pancreatic cancer. Journal of Pineal Research 49: 264-270.
30. Grant SG, Melan MA, Latimer JJ, Witt-Enderby PA (2009) Melatonin and breast cancer: cellular mechanisms, clinical studies and future perspectives. Expert Reviews in Molecular Medicine 11: e5.
31. Srinivasan V, Spence DW, Pandi-Perumal SR, Trakht I, Cardinali DP, et al. (2008) Therapeutic actions of melatonin in cancer: possible mechanisms. Integrative Cancer Therapies 7: 189-203.
32. Garcia-Navarro A, Gonzalez-Puga C, Escames G, López LC, López A, et al. (2007) Cellular mechanisms involved in the melatonin inhibition of HT-29 human colon cancer cell proliferation in culture. Journal of Pineal Research 43: 195-205. (Pubitemid 47078925)
33. Jung-Hynes B, Reiter RJ, Ahmad N (2010) Sirtuins, melatonin and circadian rhythms: building a bridge between aging and cancer. Journal of Pineal Research 48: 9-19.
34. Gonzalez A, Del Castillo-Vaquero A, Miro-Moran A, Tapia JA, Salido GM, et al. (2011) Melatonin reduces pancreatic tumor cell viability by altering mitochondrial physiology. Journal of Pineal Research 50: 250-260.
35. Um HJ, Park JW, Kwon TK (2011) Melatonin sensitizes Caki renal cancer cells to kahweol-induced apoptosis through CHOP mediated up-regulation of PUMA. Journal of Pineal Research 50: 359-366.
36. Mao L, Yuan L, Slakey LM, Jones FE, Burow ME, et al. (2010) Inhibition of breast cancer cell invasion by melatonin is mediated through regulation of the p38 mitogen-activated protein kinase signaling pathway. Breast Cancer Research 12: R107.
37. Proietti S, Cucina A, D'Anselmi F, Dinicola S, Pasqualato A, et al. (2011) Melatonin and vitamin D3 synergistically down-regulate Akt and MDM2 leading to TGFbeta-1-dependent growth inhibition of breast cancer cells. Journal of Pineal Research 50: 150-158.
38. Martínez-Campa CM, Alonso-González C, Mediavilla D, Cos S, González A, et al. (2008) Melatonin down-regulates hTERT expression induced by either natural estrogens (17beta-estradiol) or metalloestrogens (cadmium) in MCF-7 human breast cancer cells. Cancer Letters 268: 272-277.
39. Dai M, Cui P, Yu M, Han J, Li H, et al. (2008) Melatonin modulates the expression of VEGF and HIF-1 alpha induced by CoCl2 in cultured cancer cells. Journal of Pineal Research 44: 121-126. (Pubitemid 351252913)
40. Cos S, Fernández R, Guezmes A, Sánchez-Barceló EJ (1998) Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells. Cancer research 58: 4383-4390. (Pubitemid 28450041)
41. Ortiz-Lopez L, Morales-Mulia S, Ramirez-Rodriguez G, Benítez-King G (2009) ROCK-regulated cytoskeletal dynamics participate in the inhibitory effect of melatonin on cancer cell migration. Journal of Pineal Research 46: 15-21.
42. Ramirez-Rodriguez G, Ortiz-Lopez L, Benitez-King G (2007) Melatonin increases stress fibers and focal adhesions in MDCK cells: participation of Rho-associated kinase and protein kinase C. Journal of Pineal Research 42: 180-190. (Pubitemid 46233065)
43. Bellon A, Ortiz-Lopez L, Ramirez-Rodriguez G, Antón-Tay F, Benitez-King G (2007) Melatonin induces neuritogenesis at early stages in N1E-115 cells through actin rearrangements via activation of protein kinase C and Rho-associated kinase. Journal of Pineal Research 42: 214-221. (Pubitemid 46365057)
44. Tam CW, Mo CW, Yao KM, Stephen YW, Shiu SY (2007) Signaling mechanisms of melatonin in anti-proliferation of hormone-refractory 22Rv1 human prostate cancer cells: implications for prostate cancer chemoprevention. Journal of Pineal Research 42: 191-202. (Pubitemid 46233066)
45. AL-Shenbel IF, Shidata HR, Sampalis J, Jothy S (1993) Prognostic significance of proliferating cell nuclear antigen expression colorectal cancer. Cancer 71: 1954-1959.
46. Bnítez-King G, Soto-Vega E, Ramírez-Rodriguez G (2009) Melatonin modulates microfilament phenotypes in epithelial cells: implications for adhesion and inhibition of cancer cell migration. Histology and Histopathology 24: 789-799.
47. Fornas O, Mato ME, Webb SM (2000) Anti-proliferative effect and cell cycle modulation by melatonin on GH (3) cells. Hormone Research in Paediatrics 53: 251-255.
48. Mediavilla MD, Cos S, Sánchez-Barceló EJ (1999) Melatonin increases p53 and p21WAF1 expression in MCF-7 human breast cancer cells in vitro. Life Sciences 65: 415-420. (Pubitemid 29325284)
49. Tobioka H, Isomura H, Kokai Y, Tokunaga Y, Yamaguchi J, et al. (2004) Occludin expression decreases with the progression of human endometrial carcinoma. Human pathology 35: 159-164. (Pubitemid 38240897)
50. Kimura Y, Shiozaki H, Hirao M, Maeno Y, Doki Y, et al. (1997) Expression of occludin, tight junction associated protein, in human digestive tract. American Journal of Pathology 151: 45-54. (Pubitemid 27283956)
51. Davies DC (2002) Blood-brain barrier breakdown in septic encephalopathy and brain tumor. Journal of Anatomy 200: 639-646.
52. Papadopoulos MC, Saadoun S, Woodrow CJ, Davies DC, Costa-Martins P, et al. (2001) Occludin expression in microvessels of neoplastic and non- neoplastic human brain. Neuropathology and Applied Neurobiology 27: 384-395. (Pubitemid 32990079)
53. Bramwell VH, Doig GS, Tuck AB, Wilson SM, Tonkin KS, et al. (2006) Serial plasma osteopontin levels have prognostic value in metastatic breast cancer. Clinical Cancer Research 12: 3337-3343.
54. Hotte SJ, Winquist EW, Stitt L, Chambers AF (2002) Plasma Osteopontin. Cancer 95: 506-512.
55. Fedarko NS, Jain A, Karadag A, Van Eman MR, Fisher LW (2001) Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer. Clinical Cancer Research 7: 4060-4066. (Pubitemid 34044628)
56. Kim JH, Skates SJ, Uede T, Wong KK, Schorge JO, et al. (2002) Osteopontin as a potential diagnostic biomarker for ovarian cancer. The Journal of the American Medical Association 287: 1671-1679. (Pubitemid 34289219)
57. Bramwell VH, Tuck AB, Wilson SM, Stitt LW, Cherian AK, et al. (2005) Expression of osteopontin and HGF/met in adult soft tissue tumors. Cancer Biology and Therapy 4: 1336-1341. (Pubitemid 43131177)
58. Chambers AF, Behrend EI, Wilson SM, Denhardt DT (1992) Induction of expression of osteopontin (osteopontin; secreted phosphoprotein) in metastatic, ras-transformed NIH 3T3 cells. Anticancer Research 12: 43-47.
59. Oates AJ, Barraclough R, Rudland PS (1996) The identification of osteopontin as a metastasis-related gene product in a rodent mammary tumour model. Oncogene 13: 97-104. (Pubitemid 26248549)
60. Ramankulov A, Lein M, Kristiansen G, Loening SA, Jung K (2007) Plasma osteopontin in comparison with bone markers as indicator of bone metastasis and survival outcome in patients with prostate cancer. The Prostate 67: 330-340.
61. Kolega L (2003) Asymmetric distribution of myosin IIB in migration endothelial cells is regulated by a rho-dependent kinase and contributes to tail retraction. Molecular Biology of the Cell 14: 4745-4757.
62. Tohtong R, Phattarasakul K, Jiraviriyakul A, Sutthiphongchai T (2003) Dependence of metastatic cancer cell invasion on MLCK-catalyzed phosphorylation of myosin regulatory light chain. Prostate Cancer and Prostatic Diseases 6: 212-216. (Pubitemid 37185148)
63. Minamiya Y, Nakagawa T, Saito H, Matsuzaki I, Taguchi K, et al. (2005) Increased expression of myosin light chain kinase mRNA is related to metastasis in non-small cell lung cancer. Tumour Biology 26: 153-157. (Pubitemid 41379755)